Patent ID: 11938137
Assignee: PURETECH LYT, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 19:
20. The method according to claim 1, wherein a given dose of the compound or pharmaceutically acceptable salt thereof more effectively modulates the activity of one or more of B cells, dendritic cells, granulocytes, innate lymphoid cells (TLCs), megakaryocytes, monocytes/macrophages, myeloid-derived suppressor cells (MDSC), natural killer (NK) cells, platelets, red blood cells (RBCs), T cells, or thymocytes, as compared with a corresponding dose of a non-lipid prodrug form of mycophenolic acid, or a derivative, analogue, or prodrug thereof.